METHOTREXATE, BLEOMYCIN, AND HIGH-DOSE CIS-DICHLORODIAMMINEPLATIUM(II) IN THE TREATMENT OF ADVANCED EPIDERMOID CARCINOMA OF THE HEAD AND NECK

被引：0
|
作者：
CARADONNA, R
PALADINE, W
RUCKDESCHEL, JC
GOLDSTEIN, JC
OLSON, JE
JASKI, JW
SILVERS, SA
HILLINGER, S
HORTON, J
机构：
[1] UNION UNIV ALBANY MED COLL,DIV ONCOL,ALBANY,NY 12208
[2] UNION UNIV ALBANY MED COLL,DIV PATHOL,ALBANY,NY 12208
[3] MARY IMOGENE BASSETT HOSP,DEPT SURG,COOPERSTOWN,NY 13326
[4] VET ADM HOSP,ONCOL SECT,ALBANY,NY 12208
[5] ELLIS HOSP,ONCOL SECT,SCHENECTADY,NY
[6] ST CLARES HOSP,DEPT HEMATOL ONCOL,SCHENECTADY,NY
来源：
CANCER TREATMENT REPORTS | 1979年 / 63卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：489 / 491
页数：3
相关论文
共 50 条
  • [41] HIGH-DOSE CISPLATIN IN ADVANCED HEAD AND NECK-CANCER
    FORASTIERE, AA
    TAKASUGI, BJ
    BAKER, SR
    WOLF, GT
    KUDLAHATCH, V
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 19 (02) : 155 - 158
  • [42] CIS DICHLORODIAMMINEPLATINUM (CDDP) AND BLEOMYCIN (BL) VERSUS METHOTREXATE (MXT) AND VINDESINE (VD) IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    VONHEYDEN, HW
    SCHRODER, M
    BEYER, JH
    NAGEL, GA
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 167 - 167
  • [43] IMPROVED SURVIVAL IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK RESPONDING TO PREOPERATIVE HIGH-DOSE METHOTREXATE-LEUCOVORIN
    ERVIN, TJ
    WEICHSELBAUM, RR
    MILLER, D
    [J]. HEAD & NECK SURGERY, 1981, 3 (03): : 263 - 263
  • [44] COMBINATION CHEMOTHERAPY WITH CISPLATIN, BLEOMYCIN AND METHOTREXATE IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    JAHNKE, V
    [J]. ARCHIVES OF OTO-RHINO-LARYNGOLOGY-ARCHIV FUR OHREN-NASEN-UND KEHLKOPFHEILKUNDE, 1980, 227 (3-4): : 566 - 567
  • [45] TREATMENT OF ADVANCED HEAD AND NECK-CARCINOMA WITH SYNCHRONOUS IRRADIATION AND METHOTREXATE
    POINTON, RCS
    ASKILL, CS
    HUNTER, RD
    WILKINSON, PM
    [J]. CANCER TREATMENT REPORTS, 1981, 65 : 145 - 148
  • [46] INITIAL ADJUVANT WEEKLY HIGH DOSE METHOTREXATE WITH LEUCOVORIN RESCUE IN ADVANCED SQUAMOUS CARCINOMA OF HEAD AND NECK
    WEICHSELBAUM, RR
    MILLER, D
    PITMAN, SW
    KIRKWOOD, J
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1978, 4 (7-8): : 671 - 674
  • [47] CIS-DICHLORODIAMMINEPLATINUM-II (DDP), METHOTREXATE (MTX) AND BLEOMYCIN (BLM) CHEMOTHERAPY FOR PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA (SCC) OF THE HEAD AND NECK (H AND N)
    MURPHY, WK
    VALDIVIESO, M
    BODEY, GP
    FREIREICH, EJ
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 166 - 166
  • [48] HIGH-DOSE VERSUS LOW-DOSE CISPLATIN IN ADVANCED HEAD AND NECK SQUAMOUS CARCINOMA - A RANDOMIZED STUDY
    VERONESI, A
    ZAGONEL, V
    TIRELLI, U
    GALLIGIONI, E
    TUMOLO, S
    BARZAN, L
    LORENZINI, M
    COMORETTO, R
    GRIGOLETTO, E
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (08) : 1105 - 1108
  • [49] IMPROVED SURVIVAL IN PATIENTS WITH ADVANCED SQUAMOUS CARCINOMA OF HEAD AND NECK RESPONDING TO PREOPERATIVE HIGH-DOSE METHOTREXATE-LEUKOVORIN (HD-MTX)
    ERVIN, TJ
    MILLER, D
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 141 - 141
  • [50] HIGH-DOSE METHOTREXATE - A CLINICAL AND PHARMACOKINETIC EVALUATION - TREATMENT OF ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK USING A PROSPECTIVE MATHEMATICAL-MODEL AND PHARMACOKINETIC SURVEILLANCE
    FAVRE, R
    MONJANEL, S
    ALFONSI, M
    PRADOURA, JP
    BAGARRYLIEGEY, D
    CLEMENT, S
    IMBERT, AM
    LENA, N
    DISTRIA, JC
    CANO, JP
    CARCASSONNE, Y
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (03) : 156 - 160
12345